JP2003518475A5 - - Google Patents

Download PDF

Info

Publication number
JP2003518475A5
JP2003518475A5 JP2001511906A JP2001511906A JP2003518475A5 JP 2003518475 A5 JP2003518475 A5 JP 2003518475A5 JP 2001511906 A JP2001511906 A JP 2001511906A JP 2001511906 A JP2001511906 A JP 2001511906A JP 2003518475 A5 JP2003518475 A5 JP 2003518475A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
phenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001511906A
Other languages
English (en)
Japanese (ja)
Other versions
JP5010788B2 (ja
JP2003518475A (ja
Filing date
Publication date
Priority claimed from DE19935219A external-priority patent/DE19935219A1/de
Application filed filed Critical
Publication of JP2003518475A publication Critical patent/JP2003518475A/ja
Publication of JP2003518475A5 publication Critical patent/JP2003518475A5/ja
Application granted granted Critical
Publication of JP5010788B2 publication Critical patent/JP5010788B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001511906A 1999-07-27 2000-07-22 カルボン酸アミド、その化合物を含有する医薬組成物、その使用及び調製 Expired - Fee Related JP5010788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19935219.4 1999-07-27
DE19935219A DE19935219A1 (de) 1999-07-27 1999-07-27 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
PCT/EP2000/007057 WO2001007020A2 (de) 1999-07-27 2000-07-22 Carbonsäureamide, diese verbindungen enthaltende arzneimittel, deren verwendung und herstellung

Publications (3)

Publication Number Publication Date
JP2003518475A JP2003518475A (ja) 2003-06-10
JP2003518475A5 true JP2003518475A5 (https=) 2007-09-20
JP5010788B2 JP5010788B2 (ja) 2012-08-29

Family

ID=7916195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001511906A Expired - Fee Related JP5010788B2 (ja) 1999-07-27 2000-07-22 カルボン酸アミド、その化合物を含有する医薬組成物、その使用及び調製

Country Status (27)

Country Link
US (2) US6362210B1 (https=)
EP (1) EP1261321A2 (https=)
JP (1) JP5010788B2 (https=)
KR (1) KR20020032537A (https=)
CN (1) CN1414849A (https=)
AR (1) AR024944A1 (https=)
AU (1) AU6436800A (https=)
BG (1) BG106343A (https=)
BR (1) BR0013184A (https=)
CA (1) CA2378382C (https=)
CO (1) CO5180639A1 (https=)
CZ (1) CZ2002313A3 (https=)
DE (1) DE19935219A1 (https=)
EA (1) EA200200114A1 (https=)
EE (1) EE200200041A (https=)
HR (1) HRP20020072A2 (https=)
HU (1) HUP0204373A3 (https=)
IL (1) IL147707A0 (https=)
MX (1) MXPA02000822A (https=)
NO (1) NO20020374L (https=)
PL (1) PL361335A1 (https=)
SK (1) SK2962002A3 (https=)
TR (1) TR200200226T2 (https=)
UY (1) UY26256A1 (https=)
WO (1) WO2001007020A2 (https=)
YU (1) YU5502A (https=)
ZA (1) ZA200200694B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645964B1 (en) * 1999-11-29 2003-11-11 Aventis Pharma S.A. Chemical derivatives and their application as antitelomerase agent
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
DE10065042A1 (de) * 2000-12-23 2002-06-27 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US6887873B2 (en) 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
WO2002083123A1 (en) * 2001-04-18 2002-10-24 Pharmacia Italia Spa Aurones as telomerase inhibitors
FR2825090B1 (fr) * 2001-05-28 2003-08-01 Aventis Pharma Sa Derives chimiques et leur application comme agent antitelomerase
WO2002096903A2 (fr) * 2001-05-28 2002-12-05 Aventis Pharma S.A. Derives chimiques et leur application comme agent antitelomerase
GB0127615D0 (en) * 2001-07-09 2002-01-09 Aventis Pharm Prod Inc Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
JP2005518371A (ja) * 2001-12-10 2005-06-23 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療に於けるこれらの使用
US20070232572A1 (en) * 2003-02-07 2007-10-04 Aventis Pharma S.A. Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agent
WO2004082677A1 (en) * 2003-03-21 2004-09-30 H. Lundbeck A/S Substituted p-diaminobenzene derivatives
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
KR20070057965A (ko) * 2004-09-21 2007-06-07 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
JPWO2006054793A1 (ja) * 2004-11-19 2008-06-05 財団法人新産業創造研究機構 ベンゾフラン化合物、およびそれを含有してなる医薬組成物
US20070072873A1 (en) * 2005-09-27 2007-03-29 Henrietta Dehmlow Novel thiophene derivatives which are HM74A agonists
MX352516B (es) * 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
RU2470910C9 (ru) 2007-06-29 2013-05-20 Акьюсела, Инк. Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств
JP5251876B2 (ja) 2007-07-24 2013-07-31 アステラス製薬株式会社 ベンズイミダゾール誘導体
CA2709937C (en) * 2007-12-21 2016-03-22 Fibrotech Therapeutics Pty Ltd Halogenated analogues of anti-fibrotic agents
US20110054034A1 (en) * 2008-02-08 2011-03-03 Schroeder Jr William Methods of using carboxylic amides as antimicrobial agents
JPWO2010087319A1 (ja) 2009-01-27 2012-08-02 アステラス製薬株式会社 前立腺癌治療剤として有効な物質のスクリーニング方法
WO2010144959A1 (en) * 2009-06-18 2010-12-23 Fibrotech Therapeutics Pty Ltd Analogues of anti-fibrotic agents
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
ES2861268T3 (es) 2011-09-20 2021-10-06 Basf Se Moduladores de bajo peso molecular del receptor de mentol frío TRPM8 y su uso
WO2013091011A1 (en) * 2011-12-21 2013-06-27 Biota Europe Ltd Heterocyclic urea compounds
JP7185631B2 (ja) 2017-02-03 2022-12-07 サータ セラピューティクス プロプライエタリー リミテッド 抗線維化化合物
CN110357789B (zh) * 2018-04-11 2022-09-30 华东理工大学 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
CN114831977B (zh) * 2021-02-02 2023-12-19 北京大学 苯甲酸类衍生物作为trpm2蛋白抑制剂的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640710B2 (https=) * 1973-01-18 1981-09-22
JPS5848545B2 (ja) * 1974-04-18 1983-10-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
JPS6097946A (ja) * 1983-11-01 1985-05-31 Ono Pharmaceut Co Ltd カルボキサミド誘導体
JPS60139646A (ja) * 1983-12-27 1985-07-24 Otsuka Pharmaceut Factory Inc ナフタレン誘導体
JPS60146855A (ja) * 1984-01-11 1985-08-02 Ono Pharmaceut Co Ltd アニリン誘導体
JPS61170528A (ja) 1985-01-22 1986-08-01 Sutaaroi Sangyo Kk コバルトの剥離回収方法
JPH0578315A (ja) * 1991-03-11 1993-03-30 Kyowa Hakko Kogyo Co Ltd インドール誘導体
EP0511477B1 (en) * 1991-03-11 1996-07-10 Kyowa Hakko Kogyo Co., Ltd. Indole derivatives
JPH0672866A (ja) * 1992-07-02 1994-03-15 Chugoku Igakuka Gakuin Yakubutsu Kenkyusho 分化誘導剤
IT1276462B1 (it) 1995-07-03 1997-10-31 Rotta Research Lab Diamidi aromatiche acide ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico
JPH09154575A (ja) * 1995-10-04 1997-06-17 Soosei:Kk テロメラーゼ
IT1286141B1 (it) 1996-07-02 1998-07-07 Rotta Research Lab Derivati diammidici dell'acido antranilico ad attivita' antigastrinica procedimento per la loro preparazione e loro uso farmaceutico.
FR2759368B1 (fr) 1997-02-10 2001-06-01 Galderma Rech Dermatologique Composes biaromatiques, compositions les contenant et utilisations
JPH1149676A (ja) * 1997-07-31 1999-02-23 Geron Corp ピリジン系テロメラーゼ阻害剤
CN1273579A (zh) * 1997-08-05 2000-11-15 美国家用产品公司 氨茴酸类似物
DK1037880T3 (da) 1997-12-11 2004-11-15 Janssen Pharmaceutica Nv Anilider som retinsyremimetika
CA2338804A1 (en) 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
CA2348267A1 (en) 1998-10-29 2000-05-11 Henry H. Gu Novel inhibitors of impdh enzyme

Similar Documents

Publication Publication Date Title
JP2003518475A5 (https=)
JP2004530656A5 (https=)
RU2462454C2 (ru) Новое сульфонамидное производное малоновой кислоты и его фармацевтическое применение
JP2006504761A5 (https=)
JP2004525873A5 (https=)
JP2004532227A5 (https=)
CA2299139A1 (en) 4-phenyl-pyridine derivatives
JP2006508061A5 (https=)
JP2004529931A5 (https=)
CA2445341A1 (en) Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof
RU2009126624A (ru) Производные 2-(пиперидин-4-ил)-4-фенокси-или фенилаинопиримидина в качестве ненуклеозидных ингибитров обратной транскриптазы
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2004502749A5 (https=)
CA2445344A1 (en) Heterocyclic compound derivatives and medicines
CA2392570A1 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
JP2006500348A5 (https=)
IL276946B (en) Antiproliferative compounds and methods of use
JP2005513052A5 (https=)
JP2017512191A5 (https=)
Koltun et al. Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
RU2007105970A (ru) Пиперидиновые производные в качестве лигандов гистаминового из рецептора
ZA200401456B (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases.
HRP20180528T1 (hr) Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina
ZA200205551B (en) Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors.